Home > Journals > Ophthalmology and Allied Sciences

Ophthalmology and Allied Sciences

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

To Study the Changes in OCT Parameters and Visual Outcome in Wet ARMD Patients Pre-and Post-Ranibizumab Injection

Tamboli Kshitij S , Tamboli Kshitij S1 , Shanbhag Nita U2 , Jain Sanika A3 , Zarkar Jay N4

Author Information

Licence:



Ophthalmology and Allied Sciences 5(3):p 269-274, Sep-Dec 2019. | DOI: DOI: http://dx.doi.org/10.21088/oas.2454.7816.5319.3

How Cite This Article:

Tamboli Kshitij S, Shanbhag Nita U, Jain Sanika A, et al. To Study the Changes in OCT Parameters and Visual Outcome in Wet ARMD Patients Pre-and Post-Ranibizumab Injection. Ophthalmol Allied Sci. 2019;5(3):269–274

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Purpose: Our study assesses the impact of injection ranibizumab on patients with wet ARMD. We take into account OCT parameters pre- and post- administration of injection ranibizumab. We then correlate the effects of these parameters with visual outcome in these patients. Methods: This was a prospective study of 40 eyes of 40 patients in DY Patil Hospital, Nerul, Navi Mumbai over a period of 1 year. All patients were treated with monthly intravitreal ranibizumab injections (0.5 mg/0.05 ml) for 3 months. Changes in foveal photoreceptor layer integrity, choroidal neovascular membrane, diameter, thickness, central macular thickness, subretinal fluid assessment was done by spectral domain OCT at every visit and correlated with final visual outcome. Results: It was observed that intravitreal injection ranibizumab has a significant effect on improvement in OCT parameters of these patients. Also, the patients who had significant improvement in OCT had improvement in visual acuity finally. Conclusion: Intravitreal ranibizumab is a good choice of treatment in wet ARMD patients. Improvements in OCT could be correlated with visual improvement in these patients.

Keywords: Age related macular degeneration; Choroidal neo-vascularization; Ranibizumab.

References

No records found.


About this article

Cite this article

Tamboli Kshitij S, Shanbhag Nita U, Jain Sanika A, et al. To Study the Changes in OCT Parameters and Visual Outcome in Wet ARMD Patients Pre-and Post-Ranibizumab Injection. Ophthalmol Allied Sci. 2019;5(3):269–274

Licence:



Received Accepted Published
N/A N/A N/A
DOI: DOI: http://dx.doi.org/10.21088/oas.2454.7816.5319.3

Keywords


Article Level Metrics

Last Updated

Sunday 26 July 2026, 11:21:16 (IST)

577

Accesses

1
66
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share